These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18704913)

  • 21. Totally implantable central venous access devices in adult oncological patients.
    Florio G; Del Papa M; Mari A; Carnì D
    Chir Ital; 2008; 60(5):697-702. PubMed ID: 19062492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Femoral placement of totally implantable venous power ports as an alternative implantation site for patients with central vein occlusions.
    Goltz JP; Janssen H; Petritsch B; Kickuth R
    Support Care Cancer; 2014 Feb; 22(2):383-7. PubMed ID: 24061782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of approach for totally implantable venous access device decreases rate of complications.
    Karanlik H; Kurul S
    J Surg Oncol; 2009 Sep; 100(3):279-83. PubMed ID: 19582820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Venous access using a totally implantable catheter].
    Guenier C; Pector JC
    Rev Med Brux; 1988 Jun; 9(5):274-6. PubMed ID: 3413371
    [No Abstract]   [Full Text] [Related]  

  • 25. Managing an implantable drug delivery system.
    Speechley V; Davidson T
    Prof Nurse; 1989 Mar; 4(6):284-8. PubMed ID: 2762336
    [No Abstract]   [Full Text] [Related]  

  • 26. The irreplaceable image: Non-Hodgkin's lymphoma in a totally implantable subcutaneous venous access port system.
    Lopez-Cepero Andrada JM; Gutierrez De la Peña C; Guzmán Zamudio JL
    Haematologica; 2001 May; 86(5):560. PubMed ID: 11410432
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
    Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
    Clin Infect Dis; 2008 Nov; 47(9):1171-5. PubMed ID: 18808356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life in female and breast cancer patients.
    Marcy PY
    Eur J Surg Oncol; 2008 Feb; 34(2):252. PubMed ID: 17640845
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical outcome of totally implantable subcutaneous infusion port--comparison with home parenteral nutrition and chemotherapy].
    Taniguchi K; Oka K; Tokuyasu N; Naka T; Kondo A; Tsujitani S; Ikeguchi M
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):281-5. PubMed ID: 18281766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superior vena cava syndrome after subclavian vein chemotherapy port replacement in a patient with breast cancer.
    Ozcinar B; Ozmen V
    Breast J; 2007; 13(4):425-6. PubMed ID: 17593052
    [No Abstract]   [Full Text] [Related]  

  • 31. [Terminal care of cancer patients using an implanted venous reservoir].
    Nakamura S
    Gan To Kagaku Ryoho; 1999 Dec; 26 Suppl 2():273-6. PubMed ID: 10630231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simplified insertion of the Port-A-Cath implantable drug-delivery system.
    Del Campo C
    Can J Surg; 1985 Sep; 28(5):435-6. PubMed ID: 4027791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vesicant extravasation from an implanted venous access port.
    Wickham R
    Oncology (Williston Park); 2009 Apr; 23(4 Suppl Nurse Ed):34-8. PubMed ID: 19856596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical experience of a totally implantable venous catheter for gynecologic cancer patients].
    Dozono H; Kamiwatari M; Ikeda S; Shinmura R; Miwa K; Nagata Y; Unoki Y; Arima N
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):2023-5. PubMed ID: 2592825
    [No Abstract]   [Full Text] [Related]  

  • 35. Technical benefits and outcomes of modified upwardly created subcutaneous chest pockets for placing central venous ports: single-center experience.
    Lee SH; Chun HJ; Choi BG
    Acta Radiol; 2009 May; 50(4):368-73. PubMed ID: 19267272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Commentary to: Goossens, G.A., Stas, M., Moons, P., 2012. Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience. European Journal of Oncology Nursing 16 (5), 465-471.
    Hance SN; Glenn LL
    Eur J Oncol Nurs; 2012 Dec; 16(5):472. PubMed ID: 22884874
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of totally implantable venous system in cancer patients. Surgical technique and initial clinical experience].
    Ferranti F; Chichi GL; Mazzola L; Triveri P; Palmieri RM
    G Chir; 2002 May; 23(5):225-8. PubMed ID: 12228978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Central venous cannulation--the important things, you should know!].
    Szibor-Kriesen U; Rücker G; Vagts DA
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Oct; 43(10):654-63. PubMed ID: 18958817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Placing central lines in patients with implantable (port-a-cath) systems].
    Tornero Tornero JC; Gomar Sancho C
    Rev Esp Anestesiol Reanim; 2002 Dec; 49(10):561-2. PubMed ID: 12677981
    [No Abstract]   [Full Text] [Related]  

  • 40. Totally implantable vascular access device (TIVAD) placement: a modified technique that takes post-procedure aesthetic aspects into account.
    Liberale G
    Support Care Cancer; 2017 Apr; 25(4):1137-1140. PubMed ID: 27888350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.